If you like cats, but because of an allergy you can't be near, you'll soon be able to enjoy your favorite animal, thanks to the latest vaccine scientists have discovered.
People diagnosed with cat allergy are allergic to the Fel-d1 protein found in the fur of these animals. This protein attaches to the cat's dandruff and then spreads to the area in which the cat lives or resides.
When the protein Fel-d1 enters the body of a person who is allergic, there is increased secretion of histamine, which causes redness of the eyes, sneezing and difficulty breathing. This is especially dangerous for people who also have asthma or some other form of respiratory illness.
The vaccine called HypoCat is the solution for all people who have this problem. Scientists at the University Hospital Zurich, Switzerland have been working on the vaccine for more than ten years and point out that previous research and experiments have shown that it works.
The HypoCat vaccine is injected into cats, boosting their immune system and thereby helping to eliminate the Fel-d1 protein from their body, according to a report published in the Journal of Allergy and Clinical Immunology.
The vaccine is not yet available for commercial use.